Lumida
/RFIL
⌘K
RFIL

RFIL

RFIL
$10.32USD+1.28%+0.13 today

MARKET CAP

111.9M

P/E (TTM)

516.0x

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$6
$22

AI Summary

Stalk
TrimHigh

RFIL remains in a clear Stage 4 downtrend with price below all key moving averages and active Post-Parabola Collapse dynamics implying a prolonged unwind. The medium-term bias is bearish, and short-term timing is neutral as price tightly tracks below sloping EMAs without clear rejection or recovery. Execution is deferred selling, targeting a bounce into the 9/20-EMA zone. Key risks include an oversold bounce or decisive reclaim above EMA levels invalidating the bearish stance.

  • Q2 revenue up 9% YoY to $20.7M reflects solid execution
  • Gross margin rose to 35.1% (+360 bps) via pricing power
  • Negative earnings yield indicates weak profitability versus market value
Full analysis →

Buying

3

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY591.23 K12.54 M+441.26 K+711.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL463.82 K9.84 M+-30.85 K+92.9%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY98.80 K2.10 M+69.40 K+591.3%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW27.86 K590.83 K+27.86 K+0.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL13.92 K295.18 K+-29.13 K-33.5%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL3.48 K74.24 K+-7.72 K-32.1%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-45.30 K-100.0%0.00%